Trial Profile
Cross-over, double-blind, randomized, single dose euglycemic hyperinsulinemic clamp study to compare the pharmacokinetics (PK) and pharmacodynamics (PD) of NPH recombinant human insulin produced by Biomm/Bioton and the reference product Humulin® N produced by Eli Lilly in type 1 diabetic patients (T1DM).
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2018
Price :
$35
*
At a glance
- Drugs Insulin suspension isophane (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 20 Jun 2018 New trial record